National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 541076

Case Details

VAERS ID: 541076 (history)  
Form: Version 1.0  
Age: 13.0  
Gender: Female  
Location: Foreign  
Submitted: 2014-08-25
Entered: 2014-08-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J012136 / 1 AR / IM

Administered by: Other       Purchased by: Other
Symptoms: Myelitis transverse, Paraplegia
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1408DEU014061

Write-up: Information has been received from Sanofi Pasteur (Mfr control no. DE-1577272925-E2014-07330) on 22-AUG-2014. Case was received from a health care professional on 19-Aug-2014. Case is medically confirmed. Case is poorly documented. A 15-year-old previously healthy female patient received a first dose of GARDASIL, (lot-no. not reported) on an unspecified date in Jun-2014. 4 weeks later, she developed paraplegia within four hours. Diagnosis of transverse myelitis was established. She was hospitalised and currently stays in a neurological rehabilitation clinic (outcome not recovered).

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166